L Freund
Impact in
- Genetics top 5%
- Inflammatory Bowel Disease
- Epidemiology top 10%
- Microscopic Colitis
- Autoimmune and Inflammatory Disorders
Papers in ⓘ
-
- Platelet Disorders and Treatments 3
- Co-authors
- Jørn Brynskov (6 shared papers)Sten Nørby Rasmussen (4 shared papers)Mauro Campanini (3 shared papers)Jens Brøchner‐Mortensen (1 shared paper)Ove B. Schaffalitzky de Muckadell (4 shared papers)K. Lauritsen (4 shared papers)Francisco Fidencio Cons Molina (2 shared papers)A. S. Macdonald (2 shared papers)
In The Last Decade
L Freund
18 papers receiving 593 citations
Peers
Comparison fields: 5 of 79
- Genetics 347
- Epidemiology 300
- Hematology 74
- Transplantation 15
- Immunology 117
Countries citing papers authored by L Freund
This map shows the geographic impact of L Freund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Freund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Freund more than expected).
Fields of papers citing papers by L Freund
This network shows the impact of papers produced by L Freund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Freund. The network helps show where L Freund may publish in the future.
Co-authors
The 25 scholars most cited alongside L Freund, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 292 | |
| 2 | 1991 | 68 | |
| 3 | 1981 | 47 | |
| 4 | 1982 | 40 | |
| 5 | 1992 | 33 | |
| 6 | 1992 | 24 | |
| 7 | Aclarubicin in the treatment of acute nonlymphocytic leukemia refractory to treatment with daunorubicin and cytarabine: a phase II trial. | 1984 | 22 |
| 8 | 1978 | 20 | |
| 9 | Fusidic acid for Behçet's colitis: a novel approach to T-cell specific immunosuppressive therapy. | 1991 | 19 |
| 10 | 1989 | 16 | |
| 11 | 1985 | 15 | |
| 12 | 1982 | 9 | |
| 13 | 1983 | 6 | |
| 14 | 1988 | 5 | |
| 15 | Cyclosporine in inflammatory bowel disease. | 1988 | 4 |
| 16 | 1981 | 3 | |
| 17 | 1983 | 3 | |
| 18 | 1989 | 1 |
About L Freund
L Freund is a scholar working on Hematology, Transplantation, Genetics, Internal Medicine and Genetics, having authored 18 papers that have together received 627 indexed citations. Recurring topics across this work include Microscopic Colitis (5 papers), Inflammatory Bowel Disease (5 papers), Platelet Disorders and Treatments (3 papers), Chronic Lymphocytic Leukemia Research (2 papers), Immunodeficiency and Autoimmune Disorders (2 papers), Pregnancy and Medication Impact (2 papers), Metabolism and Genetic Disorders (1 paper) and Oral and gingival health research (1 paper). The work is most often cited by research in Genetics (347 citations), Epidemiology (300 citations), Hematology (74 citations), Transplantation (15 citations) and Immunology (117 citations). L Freund has collaborated with scholars based in Denmark, Italy and Canada. Frequent co-authors include Jørn Brynskov, Sten Nørby Rasmussen, Mauro Campanini, Jens Brøchner‐Mortensen, Ove B. Schaffalitzky de Muckadell, K. Lauritsen, Francisco Fidencio Cons Molina, A. S. Macdonald, Kaj Anker Jørgensen and Per Soelberg Sørensen. Their work appears in journals such as Scandinavian Journal of Gastroenterology, Alimentary Pharmacology & Therapeutics, Scandinavian Journal of Clinical and Laboratory Investigation, New England Journal of Medicine and Journal of Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.